Доступ предоставлен для: Guest
International Journal of Medicinal Mushrooms
Главный редактор: Solomon P. Wasser (open in a new tab)

Выходит 12 номеров в год

ISSN Печать: 1521-9437

ISSN Онлайн: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Mushrooms Bioactive as Prebiotics to Modulate Gut Microbiota in Relationships with Causes and Prevention of Liver Diseases (Review)

Том 22, Выпуск 6, 2020, pp. 509-519
DOI: 10.1615/IntJMedMushrooms.2020034706
Get accessGet access

Краткое описание

Over the years, the gut microbiota has become a main focus in gastroenterology and hepatology research. It is made up of billions of bacteria that can have essential functions ranging from digestion to the control of the immune response through the production of substances resulting from microbial metabolic activities. However, the liver remains the primordial organ as the first filter of toxins, nutrients, as well as its bacterial metabolic products from the intestines and passing through the portal vein which is the main junction connecting them and constituting about 75% of liver blood supply. Hence, the importance of their interactions, which, associated with the immune system, play mediating roles both in normal physiology and in the predisposition to disease, especially liver disease. In addition, possible therapeutic manifestations due to the modification of the intestinal microflora through prebiotics can come from nutrition such as mushroom consumption. Although used for food and medical needs for centuries, mushrooms have not yet fully disclosed their positive effects on health, particularly on the regulation of intestinal microbiota and subsequent effect on liver diseases. This review will present the knowledge acquired on the contribution of the intestinal microbiota to the functioning of the liver; factors causing dysbiosis, the process by which it causes disorders of intestinal homeostasis and induces the genesis of liver diseases; and the therapeutic benefits of culinary-medicinal mushrooms on the body in general through the intestinal microbiota. Mushrooms have several bioactive compounds, for example, polysaccharides such as xylans, galactans, β and α-glucans, and chitin, that justify their use as prebiotics to promote the growth of intestinal bacteria and to induce beneficial effects in the health of the host.

ЛИТЕРАТУРА
  1. Marieb EN. Anatomie et physiologie humaines. Quebec: Editions du Renouveau Pedagogique; 1999.

  2. Guyton AC, Hall EJ. Textbook of medical physiology 11th ed. Philadelphia: Elsevier; 2003.

  3. Haque TR, Barritt AS. Intestinal microbiota in liver disease. Best Pract Res Clin Gastroenterol. 2016;30(1):133-142.

  4. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, MetaHIT Consortium, Bork P, Ehrlich SD, Wang J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.

  5. Nitin J, Mithun S, Rao PN, Nageshwar DR. Liver diseases: The role of gut microbiota and probiotics. J Prob Health. 2016;4(3):154.

  6. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012; 336(6086):1268-73.

  7. Llorente C, Schnabl B. The gut microbiota and liver disease. Cell Mol Gastroenterol Hepatol. 2015;1(3):275-284.

  8. De Sousa VMC, Dos Santos EF, Sgarbieri VC. The importance of prebiotics in functional foods and clinical practice. Food Nutr Sci. 2011;2:4.

  9. Jayachandran M, Xiao J, Xu B. A critical review on health promoting benefits of edible mushrooms through gut microbiota. Int J Mol Sci. 2017;18(9):E1934.

  10. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr. 1995;125(6):1401-12.

  11. Ferrao J, Bell V, Calabrese V, Pimentel L, Pintado M, Fernandes TH. Impact of mushroom nutrition on microbiota and potential for preventative health. J Food Nutr Res. 2017;5(4):226-33.

  12. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011;9:88-96.

  13. Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr Rev. 2012;70:S38-S44.

  14. Surana NK, Kasper DL. The yin yang of bacterial polysaccharides: Lessons learned from B. fragilis PSA. Immunol Rev. 2011;245(1):13-26.

  15. Furness JB. The enteric nervous system: Normal functions and enteric neuropathies. New York: Wiley; 2008.

  16. Gershon M. The second brain: The scientific basis of gut instinct and a groundbreaking new understanding of nervous disorders of the stomach and intestine. New York: Harper Collins; 1998.

  17. Mullard A. Microbiology: The inside story. Nature. 2008;453(7195):578-80.

  18. Jasmohan SB. The relationship between the gut microbiota and liver disease. Gastroenterol Hepatol (N Y). 2015;11(9):626-628.

  19. Sharma V, Garg S, Aggarwal S. Probiotics and liver disease. Perm J. 2013;17:62-67.

  20. Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859-904.

  21. Yu LCH, Wang JT, Wei SC, Ni YH. Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. World J Gastrointest Pathophysiol. 2012;3(1):27.

  22. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Gordon JI. A core gut microbiome in obese and lean twins. Nature. 2008;457(7228):480-84.

  23. World Health Organization. Alcohol. 2017. Available from: http://www.who.int/mediacentre/factsheets/fs349/en/.

  24. Meng X, Li S, Li Y, Gan RY, Li HB. Gut microbiota's relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics. Nutrients. 2018;10(10):1457.

  25. Cho YE, Yu LR, Abdelmegeed MA, Yoo SH, Song BJ. Apoptosis of enterocytes and nitration of junctional complex proteins promote alcohol-induced gut leakiness and liver injury. J Hepatol. 2018;69(1):142-53.

  26. Biedermann L, Zeitz J, Mwinyi J, Sutter-Minder E, Rehman A, Ott SJ, Rogler G. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One. 2013;8(3):e59260.

  27. Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K, Blaser MJ. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488(7413):621-26.

  28. Walk ST, Blum AM, Ewing SAS, Weinstock JV, Young VB. Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis. 2010;16(11):1841-49.

  29. Dicksved J, Halfvarson J, Rosenquist M, Jarnerot G, Tysk C, Apajalahti J, Jansson JK. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2008;2(7):716-27.

  30. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Ley RE. Human genetics shape the gut microbiome. Cell. 2014;159(4):789-99.

  31. Nibali L, Henderson B, Tariq Sadiq S, Donos N. Genetic dysbiosis: The role of microbial insults in chronic inflammatory diseases. J Oral Microbiol. 2014;6(1):22962.

  32. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: Linking microbial infections to chronic inflammation and cancer. Cell. 2006;124(4):823-35.

  33. Nibali L, Ready DR, Parkar M, Brett PM, Wilson M, Tonetti MS, Griffiths GS. Gene polymorphisms and the prevalence of key periodontal pathogens. J Dent Res. 2007;86(5):416-20.

  34. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Furet JP. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011;6(1):e16393.

  35. Chassaing B, Etienne-Mesmin L, Gewirtz AT. Microbiota-liver axis in hepatic disease. Hepatology. 2013;59(1):328-39.

  36. Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, Gillevet PM. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol. 2012;303(6):G675-85.

  37. Hackstein CP, Assmus LM, Welz M, Klein S, Schwandt T, Schultze J, Abdullah Z. Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis. Gut. 2016;66(3):507-18.

  38. Lv G, Cheng N, Wang H. The gut microbiota, tumorigenesis, and liver diseases. Engineering. 2017;3(1):110-114.

  39. Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, Schwabe RF. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21(4):504-16.

  40. Mego M, Manichanh C, Accarino A, Campos D, Pozuelo M, Varela E, Azpiroz F. Metabolic adaptation of colonic microbiota to galactooligosaccharides: A proof-of-concept-study. Aliment Pharmacol Ther. 2017;45(5):670-80.

  41. Dudhgaonkar S, Thyagarajan A, Sliva D. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int Immunopharmacol. 2009;9(11):1272-80.

  42. Qin M, Geng Y, Lu Z, Xu H, Shi JS, Xu X, Xu ZH. Anti-inflammatory effects of ethanol extract of lion's mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), in mice with ulcerative colitis. Int J Med Mushrooms. 2016; 18(3):227-34.

  43. Xu L, Wang Q, Wang G, Wu JY. Contents and antioxidant activities of polysaccharides in 14 wild mushroom species from the forest of northeastern china. Int J Med Mushrooms. 2015;17(12):1161-70.

  44. Tao JH, Duan JA, Jiang S, Feng NN, Qiu WQ, Ling Y. Polysaccharides from Chrysanthemum morifolium Ramat ameliorate colitis rats by modulating the intestinal microbiota community. Oncotarget. 2017;8(46):80790-80803.

  45. De Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1-66.

  46. Kamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13(5):321-335.

  47. Caballero S, Pamer EG. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol. 2015;33(1):227-56.

  48. Wasser SP. Medicinal mushroom science: History, current status, future trends, and unsolved problems. Int J Med Mushrooms. 2010;12(1):1-16.

  49. Shimizu T, Mori K, Ouchi K, Kushida M, Tsuduki T. Effects of dietary intake of Japanese mushrooms on visceral fat accumulation and gut microbiota in mice. Nutrients. 2018;10(5):610.

  50. Lee I, Kim J, Ryoo I, Kim Y, Choo S, Yoo I, Bae K. Lanostane triterpenes from Ganoderma lucidum suppress the adipogenesis in 3T3-L1 cells through down-regulation of SREBP-1c. Bioorg Med Chem Lett. 2010;20(18):5577-81.

  51. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006;8(3):264-80.

  52. Frey A, Giannasca KT, Weltzin R, Giannasca PJ, Reggio H, Lencer WI, Neutra MR. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med. 1996;184(3):1045-59.

  53. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD. Mechanism by which orally administered P-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol. 2004;173(2):797-806.

  54. Feeney MJ, Dwyer J, Hasler-Lewis CM, Milner JA, Noakes M, Rowe S, Wu D. Mushrooms and health summit proceedings. J Nutr. 2014;144(7):1128S-36S.

  55. Chang CJ, Lu CC, Lin CS, Martel J, Ko YF, Ojcius DM, Wu TR, Tsai YH, Yeh TS, Lu JJ, Lai HC, Young JD. Antrodia cinnamomea reduces obesity and modulates the gut microbiota in high-fat diet-fed mice. Int J Obes. 2017;42(2):231-43.

  56. Brown DM, Roman E, Swain SL. CD4 T cell responses to influenza infection. Semin Immunol. 2004;16(3):171-77.

  57. Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: Novel insights into molecular targets and interventions using prebiotics. Benef Microbes. 2014;5(1):3-17.

  58. Saman P, Chaiongkarn A, Moonmangmee S, Sukcharoen J, Kuancha C, Fungsin B. Evaluation of prebiotic property in edible mushrooms. J Biol Chem Res. 2016;3:75-85.

  59. Clark MJ, Slavin JL. The effect of fiber on satiety and food intake: A systematic review. J Am Coll Nutr. 2013;32(3):200-11.

ЦИТИРОВАНО В
  1. Zheng Qiuxia, Sun Zongbin, Wang Zhanhui, Duan Tinghe, Xu Kai, Cai Mengmeng, Wang Bi, Corrosion and biocompatibility behaviours of microarc oxidation/phytic acid coated magnesium alloy clips for use in cholecystectomy in a rabbit model, RSC Advances, 11, 34, 2021. Crossref

  2. Cai Bingna, Pan Jianyu, Chen Hua, Chen Xin, Ye Ziqing, Yuan Huabiao, Sun Huili, Wan Peng, Oyster polysaccharides ameliorate intestinal mucositis and improve metabolism in 5-fluorouracil-treated S180 tumour-bearing mice, Carbohydrate Polymers, 256, 2021. Crossref

  3. Inyod Tanapak, Ayimbila Francis, Payapanon Achara, Keawsompong Suttipun, Antioxidant activities and prebiotic properties of the tropical mushroom Macrocybe crassa, Bioactive Carbohydrates and Dietary Fibre, 27, 2022. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain